ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

OTC Stocks Penny Stocks on the Run – International Stem Cell Corp (OTCMKTS … – SBWire (press release)

OTC Stocks Penny Stocks on the Run – International Stem Cell Corp (OTCMKTS …SBWire (press release)Stamford, CT — (SBWIRE) — 01/03/2014 — Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market … Continue reading

2014-01-03 Michael Zand NEWS

Study to infuse stem cells into coronary artery to regenerate tissue in heart … – Quad City Times

Study to infuse stem cells into coronary artery to regenerate tissue in heart …Quad City TimesMedical investigators are embarking on a study that involves infusing 10 million stem cells directly into a coronary artery of heart attack patients in an effort to regenerate tissue that otherwise would be permanently damaged. Dr. Luis Gruberg of the … Continue reading

2014-01-03 Michael Zand NEWS

Embryonic Stem Cell Therapy Hitch Fixed, Says Study – TopNews Arab Emirates

TopNews Arab EmiratesEmbryonic-Stem–Cell One of the biggest problems that comes in embryonic stem cell therapy is the immune rejection of transplanted cells. A group of researchers from a UC San Diego-led research team seems to have found the solution for the same. …read more   &nbs… Continue reading

2014-01-03 Michael Zand NEWS

Earnings & Deals: Intrexon agrees to buy stem-cell company – Gazette.Net: Maryland Community News Online

Earnings & Deals: Intrexon agrees to buy stem–cell companyGazette.Net: Maryland Community News OnlineGermantown biotechnology company Intrexon Corp. has agreed to acquire San Diego stem–cell company Medistem for about $26 million. The deal is subject to regulatory and shareholder approval. Intrexon, which makes synthetic biological products in the … and more …read more   &nbs… Continue reading

2014-01-03 Michael Zand NEWS

Embryonic stem cell rejection problem fixed, study says – U-T San Diego

Embryonic stem cell rejection problem fixed, study saysU-T San DiegoOne of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team. The cells can be made invisible to the immune system by genetically … …read more   &nbs… Continue reading

2014-01-03 Michael Zand NEWS

Stem cell transplant problem solved, UCSD-led study says – U-T San Diego

Stem cell transplant problem solved, UCSD-led study saysU-T San DiegoOne of the toughest problems facing embryonic stem cell therapy, immune rejection of transplanted cells, may have been solved, according to a UC San Diego-led research team. The cells can be made invisible to the immune system by genetically … …read more   &nbs… Continue reading

2014-01-02 Michael Zand NEWS

Researchers find new way to curb human stem cell rejection – Xinhua

Researchers find new way to curb human stem cell rejectionXinhuaWASHINGTON, Jan. 2 (Xinhua) — U.S. and Chinese scientists said Thursday they have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now … …read more   &nbs… Continue reading

2014-01-02 Michael Zand NEWS

Strategy Prevents Rejection of Stem Cell Therapies – Drug Discovery & Development

Strategy Prevents Rejection of Stem Cell TherapiesDrug Discovery & DevelopmentBiologists at UC San Diego have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now limiting the development of human stem cell therapies. …read more   &nbs… Continue reading

2014-01-02 Michael Zand NEWS
  • 1
  • …
  • 3,338
  • 3,339
  • 3,340
  • 3,341
  • 3,342
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.